Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 2
1976 11
1977 3
1978 13
1979 12
1980 16
1981 15
1982 10
1983 26
1984 17
1985 26
1986 17
1987 27
1988 33
1989 33
1990 21
1991 34
1992 26
1993 36
1994 50
1995 36
1996 44
1997 42
1998 42
1999 37
2000 43
2001 39
2002 54
2003 41
2004 42
2005 37
2006 36
2007 30
2008 35
2009 37
2010 28
2011 53
2012 47
2013 46
2014 69
2015 53
2016 65
2017 66
2018 63
2019 59
2020 83
2021 87
2022 85
2023 72
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

1,811 results

Results by year

Filters applied: . Clear all
Page 1
Butorphanol.
[No authors listed] [No authors listed] 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2023 Dec 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000262 Free Books & Documents. Review.
Maternal use of oral opioids during breastfeeding can cause infant drowsiness, which may progress to rare but severe central nervous system depression. Limited data indicate that butorphanol is excreted into breastmilk in small amounts. Butorphanol is poorly orally …
Maternal use of oral opioids during breastfeeding can cause infant drowsiness, which may progress to rare but severe central nervous system …
Butorphanol.
[No authors listed] [No authors listed] 2019 Apr 29. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2019 Apr 29. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643238 Free Books & Documents. Review.
Butorphanol is a synthetic opioid which is used as a nasal spray for treatment of migraine headaches and parenterally as a narcotic analgesic for moderate-to-severe pain or as an adjunct to general anesthesia. Butorphanol has not been linked to serum enzyme elevatio …
Butorphanol is a synthetic opioid which is used as a nasal spray for treatment of migraine headaches and parenterally as a narcotic a …
Butorphanol.
Pachter IJ, Evens RP. Pachter IJ, et al. Drug Alcohol Depend. 1985 Feb;14(3-4):325-38. doi: 10.1016/0376-8716(85)90065-1. Drug Alcohol Depend. 1985. PMID: 3888579 Review.
Butorphanol (Stadol) is a synthetic agonist-antagonist analgesic from the 14-hydroxymorphinan series. ...Side effects are sedation, nausea, elevated pulmonary vascular pressures and rarely CNS excitation. Limited respiratory depression exists. Butorphanol is a poten …
Butorphanol (Stadol) is a synthetic agonist-antagonist analgesic from the 14-hydroxymorphinan series. ...Side effects are sedation, n …
Butorphanol in perspective.
Rosow CE. Rosow CE. Acute Care. 1988;12 Suppl 1:2-7. Acute Care. 1988. PMID: 2830756 Review.
Butorphanol tartrate is a highly effective opioid agonist-antagonist analgesic with qualitative as well as quantitative differences from the pure agonists. ...The most prominent side effect is sedation, a property that is generally quite useful in the perioperative period. …
Butorphanol tartrate is a highly effective opioid agonist-antagonist analgesic with qualitative as well as quantitative differences f …
Efficacy and Safety of Butorphanol Use in Patient-Controlled Analgesia: A Meta-Analysis.
Zhu Z, Zhang W. Zhu Z, et al. Evid Based Complement Alternat Med. 2021 Jul 23;2021:5530441. doi: 10.1155/2021/5530441. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34335812 Free PMC article. Review.
CONCLUSION: Butorphanol may be used in PCA as a successful postoperative analgesia and is also associated with lower side effects. Further research is needed to verify the efficacy and safety of butorphanol....
CONCLUSION: Butorphanol may be used in PCA as a successful postoperative analgesia and is also associated with lower side effects. Fu …
Butorphanol tartrate (stadol): a review.
Vogelsang J, Hayes SR. Vogelsang J, et al. J Post Anesth Nurs. 1991 Apr;6(2):129-35. J Post Anesth Nurs. 1991. PMID: 1848891 Review.
Butorphanol tartrate (Stadol; Anaquest, Madison, WI/Bristol-Meyers Squibb, Evansville, IN) is an analgesic possessing mixed agonist-antagonist activity at opiate receptors. ...Butorphanol has been used more recently for epidural analgesia or for intravenous patient- …
Butorphanol tartrate (Stadol; Anaquest, Madison, WI/Bristol-Meyers Squibb, Evansville, IN) is an analgesic possessing mixed agonist-a …
Butorphanol inhibits angiogenesis and migration of hepatocellular carcinoma and regulates MAPK pathway.
Guo P, Hu Q, Wang J, Hai L, Nie X, Zhao Q. Guo P, et al. J Antibiot (Tokyo). 2022 Nov;75(11):626-634. doi: 10.1038/s41429-022-00565-z. Epub 2022 Sep 22. J Antibiot (Tokyo). 2022. PMID: 36131028
Butorphanol repressed malignant behaviors of tumor cells. In this study, the role of butorphanol in hepatocellular carcinoma was evaluated. Firstly, hepatocellular carcinoma cells were treated with butorphanol. The results showed that butorphanol decre …
Butorphanol repressed malignant behaviors of tumor cells. In this study, the role of butorphanol in hepatocellular carcinoma w …
Molecular Interaction Between Butorphanol and kappa-Opioid Receptor.
Ji J, Lin W, Vrudhula A, Xi J, Yeliseev A, Grothusen JR, Bu W, Liu R. Ji J, et al. Anesth Analg. 2020 Sep;131(3):935-942. doi: 10.1213/ANE.0000000000005017. Anesth Analg. 2020. PMID: 32701545 Free PMC article.
Our data indicate that butorphanol is more potent on KOR than on MOR. In addition, butorphanol acts as a partial agonist of KOR in the G-protein activation pathway and is a full agonist on the beta-arrestin recruitment pathway, similar to that of salvinorin A. ...Th …
Our data indicate that butorphanol is more potent on KOR than on MOR. In addition, butorphanol acts as a partial agonist of KO …
Drug therapy: butorphanol.
Vandam LD. Vandam LD. N Engl J Med. 1980 Feb 14;302(7):381-4. doi: 10.1056/NEJM198002143020705. N Engl J Med. 1980. PMID: 7351929 No abstract available.
Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors.
Commiskey S, Fan LW, Ho IK, Rockhold RW. Commiskey S, et al. J Pharmacol Sci. 2005 Jun;98(2):109-16. doi: 10.1254/jphs.crj05001x. Epub 2005 Jun 8. J Pharmacol Sci. 2005. PMID: 15942128 Free article. Review.
A body of evidence has been developed which indicates that a substantial selective action of butorphanol on the kappa-opioid receptor mediates the development of tolerance to butorphanol and cross-tolerance to other opioid agonists; to the production of dependence u …
A body of evidence has been developed which indicates that a substantial selective action of butorphanol on the kappa-opioid receptor …
1,811 results